Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
EOLS
#3395
Evolus, Inc. Common Stock
4.4
4
USD
+2.54%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+2.54%
Changement Mensuel
-11.55%
Evolution sur 6 mois
-30.41%
Changement Annuel
-56.60%
Clôture Précédente
4.3
3
Open
4.4
4
Bid
Ask
Low
4.4
4
High
4.4
4
Volume
43
Marchés
Actions des Marchés US
Soins de Santé
EOLS
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
43.73 M
55.69 M
56.41 M
57.94 M
63.59 M
65.06 M
—
Valuation ratios
Enterprise value
163.63 M
291.06 M
462.2 M
642.56 M
745.02 M
533.82 M
2.57 B
Price to earnings ratio
—
-6.93
-5.89
-9.25
-13.63
-8.31
-37.9
Price to sales ratio
—
3.25
2.95
2.81
2.57
1.44
7.65
Price to cash flow ratio
—
-9.7
-5.17
-16.72
-38.04
-10.14
-65.63
Price to book ratio
—
3.96
23.73
-27.48
123.99
-18.55
-39.42
Enterprise value to EBITDA ratio
-0.3
-6.6
-7.04
-16.46
-23.52
-10.38
-52.87
Profitability ratios
Return on assets %
-0.78
-0.18
-0.42
-0.33
-0.22
-0.23
-0.23
Return on equity %
2.23
-0.57
-4.02
2.98
-9.13
2.23
4.32
Return on invested capital %
-348.71
-99.05
-254.5
-206.14
-141.48
-109.74
-115.93
Gross margin %
67.64
56.32
62.4
69.54
68.46
66.33
265.53
Operating margin %
-270.73
-44.55
-43.96
-24.36
-12.92
-10.99
-48.86
EBITDA margin %
-259.64
-32.87
-37.06
-15.51
-9.82
-12.28
-54.85
Net margin %
-288.31
-46.96
-50.07
-30.52
-18.94
-17.38
-74.95
Liquidity ratios
Quick ratio
0.69
3.07
1.76
2.1
2.21
1.54
7.09
Current ratio
0.71
3.1
2.17
2.33
2.4
1.9
8.54
Inventory turnover
3.75
17.02
5.42
4.12
7.25
5.12
5.11
Asset turnover
0.25
0.43
0.68
1.1
1.26
1.3
1.34
Solvency ratios
Debt to assets ratio
0.57
0.29
0.42
0.67
0.56
0.69
2.68
Debt to equity ratio
-1.63
0.91
4.02
-6.12
23.54
-6.71
-40.11
Long term debt to total assets ratio
0.55
0.28
0.4
0.64
0.52
0.65
2.52
Long term debt to total equity ratio
-1.57
0.87
3.89
-5.82
22
-6.32
-37.64
Per share metrics
Operating cash flow per share
—
-0.67
-1.51
-0.6
-0.29
-0.66
-0.66
EBIT per share
—
-0.89
-1.17
-0.86
0.8
1.05
1.05
EBITDA per share
—
-0.66
-0.98
-0.55
-0.42
-0.57
-0.59
Total debt per share
—
1.5
1.33
2.22
2.1
2.4
9.24
Cash per share
—
2.94
0.96
1.1
1.4
0.83
3.53
Net current asset value per share
—
3.59
1.8
1.98
2.44
2.22
8.61
Tangible book value per share
—
0.2
-0.92
-1.56
-1.04
-1.43
-5.55
Working capital per share
—
2.43
0.97
1.13
1.43
1.05
4.55
Book value per share
—
1.64
0.33
-0.36
0.09
-0.36
-1.2
Nouvelles
Le PDG d’Evolus, Moatazedi, vend des actions pour 64.929$
Rui Avelar vend des actions Evolus (EOLS) pour 14.815$
Avelar Rui, directeur médical d’Evolus, vend pour 146.000$ d’actions EOLS
Le PDG d’Evolus, Moatazedi, vend pour 570.000$ d’actions
Evolus reclasse Vikram Malik en administrateur de Classe II pour équilibrer le conseil
Evolus reclassifies Vikram Malik to Class II director to balance board
Evolus, Inc. (EOLS) Q4 2025 Earnings Call Transcript
Le BPA de Evolus a dépassé les attentes, le CA en dessous des prévisions
Evolus earnings beat, revenue fell short of estimates
Résultats T4 2025 d’Evolus : croissance des revenus malgré les prévisions manquées
Evolus Q4 2025 slides: revenue growth continues despite forecast miss
Evolus, Inc. (EOLS) Matches Q4 Earnings Estimates